Jakarta Index Closes High over Good News on Covid-19 Vaccine

Translator

Ririe Ranggasari

Editor

Laila Afifa

July 14, 2020 | 06:41 pm

TEMPO.CO, Jakarta - The Jakarta Composite Index (JCI) closed with a gain on Tuesday, July 14. At the Indonesia Stock Exchange (IDX), the index climbed over good news on the progress of the Covid-19 vaccine.

JCI closed up by 14.68 bps of 0.29 percent to 5079.12. The LQ45 also gained by 0.44 percent to close at 795.33.

"Today's positive sentiment was dominated by the progress of vaccine research by Pfizer and BioNTech, with two of their vaccine candidates have been labeled 'fast track; by the FDA and are ready for mass production by the end of the year," Indo Premier Sekuritas Mino analyst said in Jakarta, Tuesday, as reported by Antara.

Today's trade saw massive selling by foreign investors, ending with a net sell of Rp160 billion.

The Indonesia Stock Exchange today saw 9.14 billion shares worth Rp7.25 trillion being traded 683,631 times. The bourse recorded 179 stocks gaining, 225 declined, and 172 unchanged.

Read: Covid-19 Pandemic, IDX: More Investors Coming

ANTARA


Fact Check: Did 3 Presidents Die Mysteriously for Refusing Covid-19 Vaccines?

24 Februari 2026

Fact Check: Did 3 Presidents Die Mysteriously for Refusing Covid-19 Vaccines?

Tempo fact check team's investigations into the deaths of the presidents of Haiti, Tanzania, and Burundi reveal no link to Covid-19 vaccine refusal.


mRNA-Based COVID-19 Vaccine Offers Unexpected Benefits for Cancer Patients: Study

21 Oktober 2025

mRNA-Based COVID-19 Vaccine Offers Unexpected Benefits for Cancer Patients: Study

However, the research team head cautioned that it is still too early to recommend the mRNA COVID-19 vaccine as a standard part of cancer therapy.


COVID-19 Cases Rise Again: Unair Expert Warns of Virus Mutations, Vaccine Gaps

11 Juni 2025

COVID-19 Cases Rise Again: Unair Expert Warns of Virus Mutations, Vaccine Gaps

An expert said that while the current COVID-19 wave isn't nearly as severe as the pandemic's peak, the public should not let their guard down.


BPOM Ensures AstraZeneca Vaccine Is No Longer Circulating in Indonesia

16 Mei 2024

BPOM Ensures AstraZeneca Vaccine Is No Longer Circulating in Indonesia

Indonesia's Food and Drug Monitoring Agency (BPOM) responded to the global withdrawal of AstraZeneca's COVID-19 vaccine.


Today's Top 3 News: Indonesia Still Provides Free COVID-19 Vaccines for Vulnerable Groups, Jakarta Produces 130 Tons of New Year's Eve Waste

2 Januari 2024

Today's Top 3 News: Indonesia Still Provides Free COVID-19 Vaccines for Vulnerable Groups, Jakarta Produces 130 Tons of New Year's Eve Waste

Here is the list of the top 3 news on Tempo English today.


Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

2 Januari 2024

Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

Indonesia's Health Ministry has announced that COVID-19 vaccines would remain free of charge for two vulnerable groups starting from January 1, 2024.


Indonesian Health Ministry Provides 4 Million COVID-19 Vaccine Doses for Free

12 Juni 2023

Indonesian Health Ministry Provides 4 Million COVID-19 Vaccine Doses for Free

The Health Ministry distributing COVID-19 vaccine doses free of charge to the public.


Jokowi Recalls Decision against Lockdown in Early Pandemic: 'I Meditate for 3 Days'

26 Januari 2023

Jokowi Recalls Decision against Lockdown in Early Pandemic: 'I Meditate for 3 Days'

President Joko "Jokowi" Widodo has again talked about his decision not to impose a lockdown at the beginning of the COVID-19 pandemic.


Indonesia Starts Offering Second COVID-19 Vaccine Booster for Public Starting Jan. 24

23 Januari 2023

Indonesia Starts Offering Second COVID-19 Vaccine Booster for Public Starting Jan. 24

Indonesian Ministry of Health is set to start administering a second COVID-19 vaccine booster for the public on Tuesday, January 24, 2023.


China Launches Second COVID-19 Booster Shot

14 Desember 2022

China Launches Second COVID-19 Booster Shot

China will offer a second COVID-19 booster dose to certain groups who received their first booster shot more than six months ago.